Diabetes Care, Vol 21, Issue 12 2116-2122, Copyright © 1998 by American Diabetes Association

ARTICLES

Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study

D Liao, RP Sloan, WE Cascio, AR Folsom, AD Liese, GW Evans, J Cai and AR Sharrett
Department of Health Evaluation Sciences, Penn State Medical College, Hershey 17033, USA. dliao@psu.edu

OBJECTIVE: To test at the population level whether people with multiple metabolic syndrome (MMS) disorders have reduced cardiac autonomic activity (CAA). RESEARCH DESIGN AND METHODS: We examined the association between the level of CAA and MMS disorders, at the degree of clustering and the segregate combination levels, using a random sample of 2,359 men and women aged 45-64 years from the biracial, population-based Atherosclerosis Risk in Communities (ARIC) Study. Supine resting 2-min beat-to-beat heart rate data were collected. High-frequency (HF) (0.15-0.35 Hz) and low-frequency (LF) (0.025-0.15 Hz) spectral powers, the ratio of LF to HF, and the SD of all normal R-R intervals (SDNN) were used as the conventional indices of heart rate variability (HRV) to measure CAA. The MMS disorders included hypertension, type 2 diabetes, and dyslipidemia. RESULTS: HRV indices were significantly lower in individuals with MMS disorders. The multivariable adjusted mean HF was 0.85 (beat/min)2 in subjects with all three MMS disorders, in contrast to 1.31 (beat/min)2 in subjects without any MMS disorder. At the segregated combination level, the multivariable adjusted means +/- SEM of HF were 1.34 +/- 0.05, 1.16 +/- 0.05, 1.01 +/- 0.17, and 1.34 +/- 0.05 (beat/min)2, respectively, for subjects without any MMS disorder, with hypertension only, with diabetes only, and with dyslipidemia only, and the means +/- SEM of HF were 0.93 +/- 0.04, 0.70 +/- 0.15, and 1.20 +/- 0.05 (beat/min)2, respectively, for subjects with diabetes and hypertension, diabetes and dyslipidemia, and hypertension and dyslipidemia. An increase in fasting insulin of 1 SD was associated with 88% higher odds of having a lower HF. The pattern of associations was similar for LF and SDNN. CONCLUSIONS: These findings suggest that MMS disorders adversely affect cardiac autonomic control and a reduced cardiac autonomic control may contribute to the increased risk of subsequent cardiovascular events in individuals who exhibit MMS disorders.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				F. Anan, T. Masaki, Y. Umeno, T. Iwao, H. Yonemochi, N. Eshima, T. Saikawa, and H. Yoshimatsu Correlations of high-sensitivity C-reactive protein and atherosclerosis in Japanese type 2 diabetic patients Eur. J. Endocrinol., September 1, 2007; 157(3): 311 - 317. [Abstract] [Full Text] [PDF]

				A. L. T. Uusitalo, E. Vanninen, E. Levalahti, M. C. Battie, T. Videman, and J. Kaprio Role of genetic and environmental influences on heart rate variability in middle-aged men Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1013 - H1022. [Abstract] [Full Text] [PDF]

				J-M Gonzalez-Clemente, C Vilardell, M Broch, A Megia, A Caixas, O Gimenez-Palop, C Richart, I Simon, A Martinez-Riquelme, J Arroyo, et al. Lower heart rate variability is associated with higher plasma concentrations of IL-6 in type 1 diabetes Eur. J. Endocrinol., July 1, 2007; 157(1): 31 - 38. [Abstract] [Full Text] [PDF]

				C. M. Burchfiel, T. N. Skelton, M. E. Andrew, R. J. Garrison, D. K. Arnett, D. W. Jones, and H. A. Taylor Jr Metabolic Syndrome and Echocardiographic Left Ventricular Mass in Blacks: The Atherosclerosis Risk in Communities (ARIC) Study Circulation, August 9, 2005; 112(6): 819 - 827. [Abstract] [Full Text] [PDF]

				H. Hemingway, M. Shipley, E. Brunner, A. Britton, M. Malik, and M. Marmot Does Autonomic Function Link Social Position to Coronary Risk?: The Whitehall II Study Circulation, June 14, 2005; 111(23): 3071 - 3077. [Abstract] [Full Text] [PDF]

				R. J. Huggett, J. Burns, A. F. Mackintosh, and D. A.S.G. Mary Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension Hypertension, December 1, 2004; 44(6): 847 - 852. [Abstract] [Full Text] [PDF]

				D. Liao, M. Carnethon, G. W. Evans, W. E. Cascio, and G. Heiss Lower Heart Rate Variability Is Associated With the Development of Coronary Heart Disease in Individuals With Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study Diabetes, December 1, 2002; 51(12): 3524 - 3531. [Abstract] [Full Text] [PDF]

				P. Hjemdahl Stress and the Metabolic Syndrome: An Interesting but Enigmatic Association Circulation, November 19, 2002; 106(21): 2634 - 2636. [Full Text] [PDF]

				E.J. Brunner, H. Hemingway, B.R. Walker, M. Page, P. Clarke, M. Juneja, M.J. Shipley, M. Kumari, R. Andrew, J.R. Seckl, et al. Adrenocortical, Autonomic, and Inflammatory Causes of the Metabolic Syndrome: Nested Case-Control Study Circulation, November 19, 2002; 106(21): 2659 - 2665. [Abstract] [Full Text] [PDF]

				J. Davies and A. Struthers Review: The potential benefits of aldosterone antagonism in Type 2 diabetes mellitus Journal of Renin-Angiotensin-Aldosterone System, September 1, 2002; 3(3): 150 - 155. [Abstract] [PDF]

				B. M. Curtis and J. H. O'Keefe Jr Autonomic Tone as a Cardiovascular Risk Factor: The Dangers of Chronic Fight or Flight Mayo Clin. Proc., January 1, 2002; 77(1): 45 - 54. [Abstract] [PDF]

				J.-i. Hayano, S. Mukai, H. Fukuta, S. Sakata, N. Ohte, and G. Kimura Postural Response of Low-Frequency Component of Heart Rate Variability Is an Increased Risk for Mortality in Patients With Coronary Artery Disease Chest, December 1, 2001; 120(6): 1942 - 1952. [Abstract] [Full Text] [PDF]

				N. Takahashi, M. Nakagawa, T. Saikawa, T. Ooie, K. Yufu, S. Shigematsu, M. Hara, H. Sakino, I. Katsuragi, T. Okeda, et al. Effect of essential hypertension on cardiac autonomic function in type 2 diabetic patients J. Am. Coll. Cardiol., July 1, 2001; 38(1): 232 - 237. [Abstract] [Full Text] [PDF]